idiopathic CD4-positive T-lymphocytopenia
idiopathic CD4-positive T-lymphocytopenia
Explore linked clinical trials. Standard reference: MONDO:00058074 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia | Bacterial Infections and Mycoses, Central Nervous System Fungal Infections, Cryptococcal meningitis, Cytopenia, DNA Virus Infections, Hemic and Lymphatic Diseases, Infections, Neuroinflammatory Diseases, Opportunistic Infections, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, autoimmune disease, central nervous system disorder, central nervous system infectious disorder, common wart, cryptococcosis, fungal infectious disease, fungal meningitis, hematologic disorder, human papilloma virus infection, idiopathic CD4-positive T-lymphocytopenia, immune system disorder, inborn error of immunity, leukocyte disorder, leukopenia, lymphopenia, meningitis, nervous system disorder, skin disorder, skin disorder caused by infection, viral infectious disease | Recruiting | Not stated | 2026-10-08 | NCT00867269 | |
| Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe) | Cytopenia, Hemic and Lymphatic Diseases, autoimmune disease, hematologic disorder, idiopathic CD4-positive T-lymphocytopenia, immune system disorder, inborn error of immunity, leukocyte disorder, leukopenia, lymphopenia | Recruiting | Phase 1 | 2026-09-28 | NCT04097561 | |
| A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia | Cytopenia, Hemic and Lymphatic Diseases, Infections, Nezelof syndrome, Opportunistic Infections, hematologic disorder, idiopathic CD4-positive T-lymphocytopenia, immune system disorder, inborn error of immunity, leukocyte disorder, leukopenia, lymphopenia | Recruiting | Phase 1 / Phase 2 | 2026-07-24 | NCT05600920 | |
| Predictive Performance of a Generative Model for Corneal Tomography After ICL Implantation | Cytopenia, Hemic and Lymphatic Diseases, hematologic disorder, idiopathic CD4-positive T-lymphocytopenia, immune system disorder, inborn error of immunity, leukocyte disorder, leukopenia, lymphopenia | Recruiting | Not stated | 2025-08-28 | NCT07146737 |